anmelden
FTSE All-Share
5.794,50
PKT
-1,39
PKT
-0,02
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.01.24 | Rio Tinto Neutral | UBS AG | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 08.01.24 | Shell (ex Royal Dutch Shell) Buy | UBS AG | |
| 08.01.24 | HSBC Buy | Jefferies & Company Inc. | |
| 05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.01.24 | BP Overweight | Barclays Capital | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 04.01.24 | BP Outperform | RBC Capital Markets | |
| 04.01.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 03.01.24 | GSK Buy | Jefferies & Company Inc. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 28.12.23 | Unilever Market-Perform | Bernstein Research | |
| 27.12.23 | GSK Equal Weight | Barclays Capital | |
| 27.12.23 | AstraZeneca Buy | UBS AG | |
| 22.12.23 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 20.12.23 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 20.12.23 | Diageo Outperform | Bernstein Research | |
| 20.12.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 20.12.23 | HSBC Sector Perform | RBC Capital Markets | |
| 19.12.23 | Rio Tinto Neutral | UBS AG | |
| 19.12.23 | Vodafone Group Buy | Deutsche Bank AG | |
| 19.12.23 | GSK Buy | Deutsche Bank AG | |
| 18.12.23 | Vodafone Group Equal Weight | Barclays Capital | |
| 18.12.23 | Unilever Market-Perform | Bernstein Research | |
| 15.12.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 15.12.23 | GSK Buy | Deutsche Bank AG | |
| 15.12.23 | Unilever Underperform | Jefferies & Company Inc. | |
| 14.12.23 | National Grid Overweight | JP Morgan Chase & Co. | |
| 13.12.23 | Rio Tinto Neutral | UBS AG | |
| 13.12.23 | Glencore Buy | UBS AG | |
| 13.12.23 | BP Buy | Goldman Sachs Group Inc. | |
| 13.12.23 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 12.12.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.12.23 | AstraZeneca Buy | UBS AG |
